Summary of Significant Accounting Policies (Details) - shares	9 Months Ended
Sep. 30, 2021	Sep. 30, 2020
Anti-dilutive securities	2,337,281	5,477,703
Series J
Anti-dilutive securities		692,220
Series C
Anti-dilutive securities	7	7
Convertible Notes Payable
Anti-dilutive securities		4,678,823
Warrant
Anti-dilutive securities	2,337,274	106,650
Stock Option
Anti-dilutive securities		3

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration